17.28 K USD
31.84 K USD
About Ventana Biotech, Inc.
Sector
Industry
CEO
Stephen D. Replin
Headquarters
Denver
Founded
1989
FIGI
BBG000BBR0Q4
Ventana Biotech, Inc. is a bioscience company, which engages in identifying, evaluating, acquiring, developing, and partnering to achieve commercialization of intellectual property in the area of drug candidates for personalized medicine. It focuses on the areas of anti-obesity and related illnesses. The company was founded on November 6, 1989 and is headquartered in Denver, CO.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VNTA is 0.0004 USD — it has decreased by −61.90% in the past 24 hours. Watch Ventana Biotech, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ventana Biotech, Inc. stocks are traded under the ticker VNTA.
VNTA reached its all-time high on Jul 6, 1990 with the price of 101.9063 USD, and its all-time low was 0.0001 USD and was reached on Jul 15, 2021. View more price dynamics on VNTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VNTA stock is 162.50% volatile and has beta coefficient of −10.25. Track Ventana Biotech, Inc. stock price on the chart and check out the list of the most volatile stocks — is Ventana Biotech, Inc. there?
Today Ventana Biotech, Inc. has the market capitalization of 93.61 K, it has increased by 47.06% over the last week.
Yes, you can track Ventana Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
VNTA net income for the last quarter is 10.24 K USD, while the quarter before that showed 16.13 K USD of net income which accounts for −36.49% change. Track more Ventana Biotech, Inc. financial stats to get the full picture.
No, VNTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ventana Biotech, Inc. EBITDA is 40.73 K USD, and current EBITDA margin is 57.97%. See more stats in Ventana Biotech, Inc. financial statements.
Like other stocks, VNTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ventana Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ventana Biotech, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ventana Biotech, Inc. stock shows the strong sell signal. See more of Ventana Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.